U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07228741) titled 'Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity' on Nov. 10.
Brief Summary: This is a 28-week, single-arm, open-label phase II clinical trial evaluating the combination of Tirzepatide and remote, supervised, tailored resistance exercise training to achieve weight loss in adult survivors of childhood acute lymphoblastic leukemia (ALL) living with obesity or overweight with comorbidity.
Primary Objective(s):
* To evaluate the effectiveness for weight loss of the combined intervention using once weekly Tirzepatide plus remote, supervised, tailored resistance exercise (three session...